BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2020
View Archived Issues
Macrophage crosstalk inflames fat
Read More
PTC Therapeutics begins first-in-human study of PTC-857 for GBA Parkinson's disease
Read More
BioTheryX describes Protein Homeostatic Modulators with BTX-1188 showing notable antitumor activity
Read More
Novel inhibitor of CBP/p300 shows promising activity in AR-positive breast cancer
Read More
KIFC1 as a new therapeutic target and biomarker in CRC
Read More
Janpix and University of Toronto patent STAT3 and/or STAT5 inhibitors
Read More
Chinese investigators identify new ER antagonists
Read More
Shenzhen Targetrx Biotechnology divulges new protein kinase inhibitors
Read More
Camphor Pharmaceuticals synthesizes CDK4 and/or CDK6 inhibitors
Read More
Janssen Pharmaceutica and Johnson & Johnson present new HBV antivirals
Read More
Phase III FIDELIO-DKD study of finerenone meets primary endpoint
Read More
Sorrento Therapeutics presents preclinical data on STI-6129 for multiple myeloma
Read More
Pan-TRK/ROS1 dual inhibitor XZP-5955 shows brain penetration, activity against mutations
Read More
FDA clears IND Application for phase I study of FT-819
Read More
Kitov initiates phase I/II study of NT-219 in advanced cancers
Read More
Liver protein improves brain function after exercise
Read More
Kymera and Sanofi partner on IRAK4 protein degraders in inflammation and immunology
Read More
ProteinQure and AstraZeneca collaborate on peptide therapeutic design
Read More
Newave begins phase I study of LP-108 in relapsed or refractory MDS, CMML or AML
Read More
Blade developing BLD-0409 in phase I for chronic liver diseases
Read More
Ziopharm's CD19-specific CAR T therapy studied in new phase I trial
Read More
Quadriga opens enrollment in phase I study of QBS-10072S in cancers with high LAT1 expression
Read More
SAR-442085 preclinical data supports its further development
Read More
Uppsala University researchers describe new urothelial bladder cancer model
Read More
